AbbVie will spend about $21 billion to buy leukemia-drug maker Pharmacyclics in its first major deal attempt since walking away from a $55 billion takeover of Shire last fall.
AbbVie to buy leukemia drugmaker Pharmacyclics for $21B
source U.S. News - News http://ift.tt/1EPWflQ
AbbVie to buy leukemia drugmaker Pharmacyclics for $21B
source U.S. News - News http://ift.tt/1EPWflQ
No comments:
Post a Comment